LAUREN RICHARDSON: Open Payments
NPI 1235416181 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$940 in 37 payments from 11 companies in 2025. Trend: 2023 $834 · 2024 $942 · 2025 $940
Food & beverage: $940
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $244 |
| Novo Nordisk Inc | 4 | $167 |
| ABBVIE INC. | 17 | $142 |
| Phathom Pharmaceuticals, Inc. | 1 | $122 |
| PFIZER INC. | 3 | $77 |
| Novartis Pharmaceuticals Corporation | 3 | $59 |
| Amgen Inc. | 2 | $33 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
Products named: FARXIGA, VOQUEZNA, QULIPTA, AIRSUPRA, NURTEC ODT, LEQVIO, UBRELVY, OTEZLA.
Industry payments across VA — which companies pay providers there.
